Primary Sjögren Syndrome
24
6
6
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.2%
1 terminated out of 24 trials
90.9%
+4.4% vs benchmark
0%
0 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (24)
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Primary Sjogren Syndrome
Exploring the Novel Value of PSMA PET in Sjögren's Syndrome: Integrated Analysis With Established FAPI PET Imaging
A Study of RSLV-132 in Females With Sjögren's Disease
Eye Dryness Evaluation in Primary Sjögren's Syndrome
Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine
Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for pSS Glandular Damage
Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome
Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome
68Ga-P16-093 PET/CT Imaging in the Salivary Gland
A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS)
Sjögren and Gynecologic Considerations
Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.
Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions
Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
Vaccine Coverage and Primary Sjögren'Syndrome
Biomarkers in Primary Sjögren's Syndrome